(Q35642311)

9 August 2017

title

In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents (English)

1 reference

9 August 2017

Tsuji A

1

1 reference

9 August 2017

Maniatis A

series ordinal

2

1 reference

9 August 2017

Bertram MA

series ordinal

3

1 reference

9 August 2017

Young LS

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

27

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

515-519

1 reference

The new beta-lactamase-stable cephalosporins

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

In vitro activity of HR 810, a new cephalosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180087

Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3839120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relation between beta-lactamase production and antimicrobial activity: Comparison of the new compound HR 810 with cefotaxime

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3839120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3839120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.27.4.515

1 reference

9 August 2017

1 reference

9 August 2017

1 reference